相关实验视频

Updated: Jul 16, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

移动脊柱冠状肉瘤:关于在单一机构治疗的患者的最新情况

Daniel G Tobert¹, Sidney Messier², Andrew J Schoenfeld¹

¹Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA.

|May 6, 2024

概括

完整的瘤切除 (R0) 和较低的瘤等级改善了移动脊柱软骨瘤的存活率. 转移性疾病与复发和不良结果有关,强调需要有效的治疗策略.

科学领域:

整形瘤学整形瘤学
脊柱外科手术脊柱外科手术
骨瘤骨瘤是指骨上的瘤.

背景情况:

移动脊柱的软骨肉瘤是一种罕见且具有挑战性的诊断.
关于移动脊柱软骨肉瘤治疗结果的先前研究是有限的,并且经常受到尾或盆腔数据的影响.
这项研究提供了来自单一机构的临床数据的最新分析,其结果是十多年前的一份报告.

研究的目的:

报告为移动脊柱软骨髓瘤治疗的患者的临床数据和结果.
分析影响患者生存和疾病复发的预后因素.

主要方法:

这是一项回顾性研究,包括在2007年至2020年期间接受移动脊柱软骨瘤治疗的成年患者.
排除患有大阴道瘤,转移性疾病或正在接受息手术的患者.
仅包括那些在原发瘤部位接受了确定的手术的患者.

主要成果:

包括24名患者;17人实现了负 (R0) 边际,死亡率为18%.
七名患者有正边缘 (R1或R2),死亡率为43%.
较高的总辐射剂量是与结果相关的显著共变量 (HR=1.18,P=0.03).

结论:

完整的瘤切除 (R0) 和较低的组织学等级与改善的整体存活率有关.
转移性疾病的发展与局部复发和较差的存活率密切相关.
尽管治疗方面取得了进步,但移动脊柱软骨瘤的结果仍然与早期研究报告的结果相似.

更多相关视频

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice

Published on: December 27, 2024

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...